Although knowledge about SOD2 in brain tumours is limited, recent studies suggest that reduced SOD2 levels correlate with lower tumour proliferation and longer survival in TMZ‐resistant GBM models [80]. This evidence concerns the gene SOD2 and brain neoplasm.